“The trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. This study, known as the COVE study, enrolled more than 30,000 participants in the U.S,” the company said in a statement…
NIAID Contract Obligates Pentagon to Buy 500,000,000 Doses of Moderna’s COVID Vaccine for $9 Billion…
Contract obtained through Freedom of Information Act raises questions about Fauci, transparency and conflicts of interest…